To Fight Drug Shortages FDA Has an Idea: Import More Inspection-Free Drugs
The balance between scarcity and supply favors supply, even if that means importing drugs from labs the FDA has not inspected.
The balance between scarcity and supply favors supply, even if that means importing drugs from labs the FDA has not inspected.
Meet the Chinese companies banned by Commerce and the State Department, but still able to attract billions from Wall Street fund managers.
House Homeland Committee leadership say DoJ, FBI, and Homeland have all failed in stopping China espionage, IP theft.
At a recent House Ways & Means subcommittee hearing on trade, CEO Michael Stumo talks de minimis, and the inescapable realities of China’s forced labor.
Dan Kildee’s full floor speech in support of over-riding the President’s veto on House and Senate vote to end the White House solar emergency declaration started last June.
Solar imports are booming thanks in large part to White House’s two year ban on tariffs against China companies in SE Asia.
In latest House Select Committee on China hearing, more tariffs, more Wall Street bans, and more tech restrictions are warranted.
A House Foreign Affairs Subcommittee hears from witnesses about how to curtail exports of critical technologies to China. Some say there are too many lists.
The U.S. is increasingly reliant on imported drugs from uninspected labs. It’s not safe. What can be done about it?
A look at recent studies on whether companies are sourcing manufactured goods from outside of China (they are), and if any of it that manufacturing is coming home since tariffs were imposed in 2018.